ArticleJournal of the American Heart Association2025
Inpatient-Onset Versus Outpatient-Onset ST-Segment-Elevation Myocardial Infarction in Patients With Percutaneous Coronary Intervention: A National Registry Study.
Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Influence of age on the development of stress hyperglycemia during first-onset ST-elevation myocardial infarction.Journal of diabetes investigation · 2026Article
- Development of a risk score for intramyocardial hemorrhage in elderly STEMI patients after primary PCI: a retrospective cohort study with propensity score matching analysis.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCompared with patients who develop ST-segment-elevation myocardial infarction (STEMI) outside the hospital and present at the emergency department (outpatient-onset), patients with inpatient-onset STEMI may paradoxically experience a poorer prognosis due to underlying disease, despite the apparent immediate access to acute health care services.
methodsPatients with first-onset STEMI who underwent percutaneous coronary intervention (PCI) in the Singapore Myocardial Infarction Registry (2007-2020) were included. For patients with inpatient-onset STEMI, the recognition-to-balloon time was measured from symptom onset to PCI. For outpatient-onset STEMI, the recognition-to-balloon time was defined as the sum of the symptom-to-door and door-to-balloon time. Logistic regression was used to identify factors associated with delayed PCI after inpatient-onset STEMI. Cox regression was used to assess 30-day, 1-year, 5-year, and 10-year all-cause and cardiovascular mortality.
resultsA total of 19 149 patients, 17 659 (92.2%) outpatient-onset and 1595 (7.8%) inpatient-onset, were included. The median follow-up duration was 6.91 years. Patients with inpatient-onset STEMI were older, more frequently women, nonsmokers, more likely to have comorbidities, less likely to present with typical STEMI symptoms, and more likely to experience delays in PCI than patients with outpatient-onset STEMI within the hospital setting. The independent predictors of delayed PCI for inpatient-onset STEMI were age ≥65 years, diabetes, breathlessness at presentation, and Killip class III. After adjustment for differences in baseline and clinical characteristics, inpatient-onset STEMI was associated with significantly greater 1-year, 5-year, and 10-year all-cause mortality (1-year hazard ratio [HR], 1.27 [95% CI, 1.13-1.43]; 5-year HR, 1.27 [95% CI, 1.13-1.43]). There was no difference in 30-day all-cause or short-/long-term cardiovascular mortality.
conclusionsInpatient-onset STEMI was linked to an increased long-term risk of all-cause mortality compared with outpatient-onset STEMI despite a shorter recognition-to-balloon time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.